Trade Bionano Genomics, Inc. - BNGO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0062 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.2016 |
| Open | 0.2012 |
| 1-Year Change | -84.28% |
| Day's Range | 0.1851 - 0.2019 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | 0.1863 | -0.0158 | -7.82% | 0.2021 | 0.2036 | 0.1839 |
| Jan 16, 2025 | 0.2016 | 0.0054 | 2.75% | 0.1962 | 0.2057 | 0.1730 |
| Jan 15, 2025 | 0.1955 | -0.0114 | -5.51% | 0.2069 | 0.2125 | 0.1901 |
| Jan 14, 2025 | 0.2024 | -0.0177 | -8.04% | 0.2201 | 0.2492 | 0.1989 |
| Jan 13, 2025 | 0.2195 | -0.0001 | -0.05% | 0.2196 | 0.2214 | 0.2009 |
| Jan 10, 2025 | 0.2252 | -0.0010 | -0.44% | 0.2262 | 0.2330 | 0.2063 |
| Jan 8, 2025 | 0.2246 | -0.0348 | -13.42% | 0.2594 | 0.2629 | 0.2089 |
| Jan 7, 2025 | 0.2664 | -0.0069 | -2.52% | 0.2733 | 0.2736 | 0.2498 |
| Jan 6, 2025 | 0.2691 | -0.0441 | -14.08% | 0.3132 | 0.3189 | 0.2627 |
| Jan 3, 2025 | 0.3123 | 0.0077 | 2.53% | 0.3046 | 0.3728 | 0.2715 |
| Jan 2, 2025 | 0.2473 | -0.0446 | -15.28% | 0.2919 | 0.3113 | 0.2473 |
| Dec 31, 2024 | 0.2844 | -0.0605 | -17.54% | 0.3449 | 0.3449 | 0.2488 |
| Dec 30, 2024 | 0.2712 | 0.0546 | 25.21% | 0.2166 | 0.3428 | 0.1992 |
| Dec 27, 2024 | 0.2075 | -0.0037 | -1.75% | 0.2112 | 0.2171 | 0.2042 |
| Dec 26, 2024 | 0.2089 | 0.0068 | 3.36% | 0.2021 | 0.2222 | 0.1982 |
| Dec 24, 2024 | 0.1964 | -0.0068 | -3.35% | 0.2032 | 0.2047 | 0.1910 |
| Dec 23, 2024 | 0.1966 | -0.0017 | -0.86% | 0.1983 | 0.2004 | 0.1939 |
| Dec 20, 2024 | 0.1959 | 0.0026 | 1.35% | 0.1933 | 0.2024 | 0.1915 |
| Dec 19, 2024 | 0.2011 | -0.0110 | -5.19% | 0.2121 | 0.2121 | 0.1919 |
| Dec 18, 2024 | 0.2104 | -0.0037 | -1.73% | 0.2141 | 0.2184 | 0.2069 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Bionano Genomics, Inc. Company profile
Bionano Genomics (BNGO) is a provider of solutions for genome analysis. Additionally, the company offers diagnostic services, software and optical genome mapping solutions for basic, translational and clinical research applications.
Based in San Diego, California, the company has two businesses: Lineagen and BioDiscovery.
Lineagen provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental impairments.
Through BioDiscovery, the company also offers an industry-leading, platform-diagnostic software solution. Integrating next-generation sequencing and microarray data to analyse, visualise, interpret, and report copy number variants, single-nucleotide variants, and the absence of heterozygosity across the genome in a single consolidated view.
In October 2021, Bionano Genomics bought Biodiscovery, a software company that provides solutions for analysing, interpreting and reporting genomics data.
The acquisition is expected to accelerate the adoption of optical genome mapping (OGM), with the integration of BioDiscovery's NxClinical software solution. Saphyr System is Bionano’s featured product for OGM.
Saphyr is an ultra-sensitive genome analysis platform that can detect structural variations for mosaic samples or heterogeneous cancer samples with a false positive rate of less than 2%.
The company, founded in 2003, sells its products for research use in laboratories associated with academic and governmental research institutions. For North America and Europe, Bionano sells its products through a direct sales force. It also sells its products via third party distributors in China, Japan, South Korea, Singapore, Australia, India and South Africa.
Bionano became a public company in September 2018. Its shares are traded on the Nasdaq under the ticker symbol BNGO.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
9640 Towne Centre Drive
9640 Towne Centre Drive
SAN DIEGO
CALIFORNIA 92121
US
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com